Company intelligence / Profile preview

Shanghai Kehua Bio-engineering

Shanghai, Shanghai, China

Ownership: Private
Employees: ~2151
Development stage: Other

Overview

Shanghai Kehua Bio-engineering is a leading China-based developer and manufacturer of in vitro diagnostic (IVD) products, including CE-marked and WHO-prequalified kits for HIV and other diseases, with a broad international footprint spanning over 100 countries. The company has recently achieved EU IVDR Class D CE mark for its HIV detection kit and regulatory approvals for several other diagnostic platforms[3][4][5][6].

Therapeutic areas: EndocrinologyMetabolic DisordersInfectious DiseasesCardiovascularOncology
Modalities: Diagnostic kitMolecular diagnosticsImmunoassayBiochemical diagnosisPoint-of-care testing device
Industry: Molecular Diagnostics

Partnerships

bioMérieux

Beyond the preview

Go deeper on Shanghai Kehua Bio-engineering.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Kehua Bio-engineering.

Explore the full profile